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Abstract: The deep ocean is the largest habitat for life on Earth, though the microorganisms that occupy
this unique environmental niche remain largely unexplored. Due to the significant logistical and
operational challenges associated with accessing the deep ocean, bioprospecting programmes that seek
to generate novel products from marine organisms have, to date, focused predominantly on samples
recovered from shallow seas. For this reason, the deep ocean remains a largely untapped resource of
novel microbiological life and associated natural products. Here we report the establishment of the
Bristol Sponge Microbiome Collection (BISECT), a unique repository of deep-sea microorganisms and
associated metabolites isolated from the microbiota of marine sponges, recovered from previously
unsurveyed regions of the mid Atlantic Ocean, at depths of 0.3–3 km. An integrated biodiscovery
pipeline comprising molecular, genetic, bioinformatic and analytical tools is also described, which is
being applied to interrogate this collection. The potential of this approach is illustrated using data
reporting our initial efforts to identify antimicrobial natural product lead compounds. Prospects for
the use of BISECT to address allied pharmaceutical needs, along with mechanisms of access to the
collection are also discussed
Keywords: natural products; microbiology; antibiotics; extremophiles; bioprospecting; actinomycetes
1. Introduction
Natural products and their derivatives are preeminent sources of lead compounds for
pharmaceutical development, accounting for >50% of all small molecule-based drugs in current
clinical use [1,2]. The influence of natural product chemistry on drug discovery has not materially
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decreased for more than 30 years, with drug approval statistics over the past decade providing
unequivocal evidence that natural product scaffolds remain the ideal starting point for the development
of new medicines [3]. Despite this, enthusiasm for natural products within the pharmaceutical
industry has progressively waned since the early 1990s, usurped by structure-guided approaches
and combinatorial chemistry. Regrettably, the decision to transition away from natural products as a
starting point for drug discovery has led to a decline in the productivity of the pharmaceutical industry,
with a consensus now emerging that natural product-based discovery approaches were prematurely
jettisoned [4,5].
One of the major criticisms levelled at natural product-based approaches is the high probability of
compound rediscovery [6]. Repeated screening of environmental isolates from geographically-related
sampling sites frequently delivers molecules that are too similar to known compounds to make
commercial development tractable. A further complication is that many of the microbial gene clusters
that encode the biosynthetic machinery required to assemble natural product scaffolds are inactive,
repressed or ‘silent’ under standard laboratory culturing conditions [7]. This combination of chemical
redundancy and dormant metabolism reduces the likelihood of isolating novel bioactive compounds,
even from sizeable culture collections.
One solution to the problem of rediscovery is to employ a sampling approach that targets previously
unexplored environmental niches. By focusing on such environments, the risk of compound rediscovery
is significantly reduced [8,9]. Marine ecosystems have long been viewed as an attractive source of
novel microorganisms and associated natural products [10]. Marine bioprospecting programmes have
in particular targeted sponges (Porifera); ancient metazoans that have existed for ~600 million years.
These sessile organisms are known to host a diverse microbiome comprising a plethora of bacteria
and fungi, which biosynthesise numerous bioactive compounds, including antimicrobial, antiviral,
antifungal and anticancer agents [11,12]. The microbes that make up the sponge microbiome produce
these bioactive compounds for their own protection and to compete with other microorganisms
for resources, thus potentially contributing to the protection of the sponge against pathogens [13].
As pioneer marine colonizers, sponges are highly evolved and well-suited to survival in extreme
environments, including the deep ocean. Consequently, the microbiota housed by the sponge
can be subjected to extremes of pressure and temperature, and receive minimal exposure to light.
These conditions necessitate the development of metabolic innovations, which in turn translate into
novel biosynthetic capabilities and resulting natural product chemistries [14].
Historically, bioprospecting programmes targeting sponges and their microbiota have focused on
specimens recovered from shallow waters. This is a direct consequence of the operational challenges
associated with material recovery from the deep ocean [15]. However, recent progress in the
development of unmanned remotely operated vehicles (ROVs), which can be deployed to recover
sponge samples from previously inaccessible deep-sea niches, is now unlocking new opportunities for
natural product screening programmes targeting these unique biological samples.
Here we report the establishment of the Bristol Sponge Microbiome Collection (BISECT), a growing
collection of marine microorganisms isolated from a unique repository of 75 mid-Atlantic deep-sea
sponge tissue samples. Significantly, each sponge sample within the collection was recovered from a
previously unsurveyed marine niche using an ROV deployed from the RRS James Cook. Our hope
is this unique niche allows BISECT to expand the total microbial diversity and function of similar
repositories: such as at the Marine Biodiscovery Center [16] and Fundación MEDINA’s collection [17].
Allied to the development of this collection, we also describe an end-to-end biodiscovery pipeline
comprising a suite of in vivo, in vitro and in silico tools, which are being applied to establish the
biosynthetic potential of the contents of BISECT. To exemplify our approach, we present data relating to
our initial attempts to screen this collection for the presence of antimicrobial natural products. Finally,
we outline mechanisms of access to the collection in an effort to nucleate interest and engagement from
academic colleagues, and to maximise the impact of BISECT on the research community.
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2. Results
2.1. Sponge Sample Collection
In 2013 the Tracing Ocean Processes Using Corals and Sediments (TROPICS) research cruise
(RRS James Cook, expedition JC094) collected a series of marine samples including Porifera (sea sponge)
from five different sites across the equatorial Atlantic between Tenerife and Trinidad (Figures 1a and
2a). Sampling was executed on the seabed at depths of between 298 and 2985 m using a remotely
operated vehicle (ROV) (Figure 1b), furnished with a robotic arm or suction device (Figure 1d).
Two-thirds of the sponges were collected at depths of 1 km or greater (Figure 2b). The properties of the
seawater were measured for some sampling sites, and ranged between salinities of 34.86–35.09 PSU,
oxygen concentrations of 36.77–236.25 µmol/kg, and temperatures of 2.8–9.9 ◦C. A range of different
marine Porifera were selected from the Demospongiae (common sponge), Calcarea (calcareous sponge)
and Hexactinellida (glass sponge) taxa (Figure 2c). Once at the surface, samples were photographed,
subsampled and then frozen at −80 ◦C for the return journey back to Bristol.
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2.2. Isolation of Strains Producing Active Compounds
2.2.1. Bacterial Culturing and Isolation
Six sponge tissue samples, known by the in-house unofficial designation B01607, B01641, B01661,
B0789, B0078 and B01171 (Table 1) were washed in artificial sea water (ASW) in order to reduce the
number of non-sponge-associated bacterial cells, then homogenised in a pestle and mortar and spread
onto a v riety of different agars (Supplementary Table S1) containing ASW. It was understood that that
the methods of colle ting the sponge samples and culturing the strains was not inf llible, and the strains
could not be efinitely identified as ‘sponge-associated’, but by was ing the samples we could i crease
confidence that the majority were bacteria from the sponge and not contaminants. Isolation protocols
were improved successively with each sponge by using a wider range of media each time (Table 2) and
deliberately favouring agars known to promote the growth of actinomycetes strains. The agar plates
were incubated at 28 ◦C or 4 ◦C for 4–10 weeks. Temperature was found to be an important variable
with a higher number of isolates being recovered at 28 ◦C for all sponges, albeit with considerable
differences in this ratio between the different sponges. Individual colonies were picked according to
their morphology and maintain d on agar plates at their isolation temperature for up to four weeks.
For long term storage confluent cultures of each isolate were supplemented with glycerol (20% final
concentration) and flash frozen in liquid nitrogen prior to archival at −70 ◦C.
Table 1. Sponge samples used in this study. Sample ID is the in-house nomenclature.
Order of
Processing
Sample
ID
Latitude
(N)
Longitude
(W) Depth (m)
Sampling
Region Visual ID
Total Bacterial
Isolates a
1 B01607 10◦96′49′′ 44◦36′58′′ 2887 Vema fracturezone Hexactinellid 37
2 B01641 14◦53′3′′ 48◦7′27′′ 868 Vayda seamount Hexactinellid 55
3 B01661 14◦51′47′′ 48◦14′29′′ 1483 Vayda sea t Demosponge 73
4 B0789 14◦53′25′′ 48◦9′7′′ 824 Vayda seamount Hexactinellid 136
5 B0078 5◦37′30′′ 26◦57′29′′ 971 Knipovichseamount Demosponge 182
6 B01171 5◦35′43′′ 25◦58′28′′ 2257 Knipovichseamount Demosponge 229
a As the project progressed, sponges were processed with an increasing diversity of media conditions, thus the
numbers of total bacterial isolates are not directly comparable between samples.
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Table 2. Conditions used to culture bacteria from sponge samples. See Table S1 for agar constituents.
Colonies Isolated
Sponge Sample Agar Type
28 ◦C 4 ◦C
B01607
AIA-XO 0 0
Marine 19 19
Peptone-starch 0 0
TOTAL 19 19
B01641
AIA-XO 17 0
Marine 30 9
Peptone-starch 1 0
TOTAL 48 9
B01661
AIA-XO 0 0
Marine 52 20
Peptone-starch 8 0
TOTAL 60 20
B0789
60:40 2 1
AIA 16 11
AIA-XO 4 -
Basic 7 4
Marine 43 21
Peptone-starch 10 18
TOTAL 82 55
B0078
60:40 10 0
ISP2 50 0
M1 25 1
Marine 23 4
Peptone-starch 11 0
R2A 27 4
SCA 27 0
TOTAL 173 9
B01171
60/40 7 3
ISP2 17 5
ISP2/10 7 4
ISP4 4 3
M1 5 2
MB1/2 11 10
MB20 9 10
MB20-NO3 3 -
Mucin 7 13
Peptone-starch 22 7
R2A 3 5
SA1 8 0
SAC 12 0
Spicule-extract 12 8
TOTAL 127 70
2.2.2. Screening of Isolated Strains for Antibiotic Activity
Each isolated marine strain was initially screened for antimicrobial activity against a panel of
pathogenic bacteria for which new antibiotics are critically needed: Staphylococcus aureus Newman and
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Mu50, Pseudomonas aeruginosa PAO1, Klebsiella pneumoniae NCTC 5055, Acinetobacter baumannii ATCC
19606, and Escherichia coli BW25113 (Supplementary Table S2). Various whole colony activity assays
were trialed, including the cross-streak method [18], the agar plug diffusion method [19] and the soft
agar overlay method (modified from Anand et al., 2006) [20]. In our hands the soft agar overlay assay
yielded the most consistent results and allowed high throughput testing of a large number of isolates
(data not shown). Figure 3a demonstrates the proportion of sponge isolates that inhibited the growth of
pathogens in these soft agar overlay assays. Overall, 6.2% (43/699) of our isolates showed antibacterial
activity. Isolates that only showed activity against Gram-positive pathogens were more common than
those which showed activity against Gram-negative pathogens (Figure 3a). In an effort to increase
the number and variety of isolated strains and ‘hits’, we progressively increased and diversified the
isolation media for each different sponge that we processed. This resulted in a larger proportion
of isolates that displayed antibacterial activity (Figure 3b). Just 0.6% of isolates from the first three
sponges (B01607, B01641 and B01661) had activity (1/166), compared to 4.6% for the next two sponges
(B0789 and B0078; 6/131 and 8/174) and 13% for the final sponge (B01171; 28/213). The strains with
antimicrobial activity from sponge B01171 are shown in Supplementary Table S3.
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(b) The percentage of isolates with antibacterial activity isolated from sponges B01607 + B01641 + B01661
(total from ll three sponges), B0789, B0078 and B01171. Sum is the overall percentage considering all
samples shown.
2.3. Composition of Cultured Bacteria
2.3.1. Distribution of I olated Strains from Sponges B01641, B01661, B0789 and B0078
Bacterial strains were selected from the isol tion plates based on distinct morphologies,
media comp sition and isol tion temperatu e. Therefore, the bacteria chosen for further analysis are not
the entirety of the cultured bacteria, but rather provide a representative overview of unique culturable
isolates. Fifty-five strains were isolated from sponge B01641, 73 strains from B01661, 137 strains from
sponge B0789 and 182 strains from B0078. 16S rRNA gene sequencing and subsequent BLAST analyses
were complet d for 28 isolates from B01641 (51%), 27 isolates from B01661 (37%), 47 isolates from
B0789 (34%) and 149 isolates from B0078 (82%). Bacteria identified from the genera Staphylococcus (52)
and Cutibacterium (9), along with the species Pseudomonas aeruginosa (6) and Escherichia fergusonii (5),
were excluded from the analysis du to the high likelihood that they represent contamination rather
than authe tic marin b teria.
A total of four bacterial phyla were cultured from the sponge samples: Proteobacteria (n = 48),
Bacteroidetes (n = 43), Actinobacteria (n = 39) and Firmicutes (n = 15). There were notable differences
in phyla and genera of strains recovered in sample B0078 compared to the earlier sponges. As listed in
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Table 2, extracts from B0078 were inoculated on different media compositions, as well as supplemented
with additives. After processing sponges B01641, B01661 and B0789 we chose to alter the isolation agars
for B0078 to more actinomycetes-selective media types, and to add nalidixic acid to prevent the growth
of fast-growing Gram-negative bacteria [21]. We otherwise deliberately avoided actinomycete-enriching
pretreatments on our isolation plates because several studies have indicated that these procedures,
which were developed for terrestrial actinomycetes, eliminate deep-sea actinomycetes [22–24].
These measures proved successful in isolating an increased number of strains of Actinobacteria
and a decreased number of Bacteroidetes. Whilst only 1 strain of Actinobacteria was cultured from
B01641, B01661 and B0789, 37 Actinobacteria were recovered from B0078. No bacteria from the phyla
Bacteroidetes were recovered from sponge sample B0078 (Figure 4). The Actinobacteria primarily
consisted of the genus Micrococcus (n = 24), with the remainder represented by the genera Kocuria
(n = 10), Micromonospora (n = 2), Modestobacter (n = 1), Citricoccus (n = 1) and Chryseoglobus (n = 1).
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Figure 4. Distribution of bacterial isolates cultured from four deep-sea sponge samples.
Molecular taxonomy is based on 16S rRNA gene sequences either at the phylum level (outer circle) or
the genus level (inner circle).
Representatives from 8 different genera were recovere fr , fr
B0078 and 12 genera from sponge B0789 (Figure 4). The tot l i s
spread across 26 genera. The highest number of genera (n = 11) belonged to the phylum Proteobacteria,
6 genera were recovered from Bact r idetes and Actinobacteria, with only three genera recovered from
the phylum Firmicutes. No single genus was isolated from all four sponge samples, but Psychrobacter,
Pseudoalteromonas and Nonlabens were all recovered fr m the first three sp nges (B01641, B01661 and
B0789). Considering the higher level of 16S rRNA gene sequence sampling for sponge B0078,
bacterial diversity does appear to be higher for B0789, but this is a likely consequence of the use of more
Actinobacteria-appropriate edia and the inclusion of antibiotics to limit the growth of fast-growing
Gram-negative bacteria.
2.3.2. Phylogenetic Relationship of Cultured Actinobacteria
A phylogenetic tre was constructed of isolates usin rti l ( r i t l ) r
gene sequences belongi to the Actinobacteria phylum (Figure 5). Twenty-one Acti obacteria isolates
are represented in the tree, of which 20 belong to the order Actinomycetales and one to the order
Geodermatophilales (Modestobacter 28ISP2-11). Twelve isolates are allocated to the Micrococcus genus,
four to Kocuria, two to Micromonospora, one to Chyrseoglobus, one to Citrococcus and one to Modestobacter.
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Figure 5. Phylogenetic tree of selected Actinobacteria bacterial strains isolated from deep-sea sponges
B0789 and B0078. The trees were constructed by comparison of a ~1400-bp region of the 16S rRNA
gene sequence using neighbour-joining analysis with Tamura-Nei model. Bootstrap values expressed
as percentages of 1000 replications and branches with less than 60% bootstrap support not displayed.
Bacillus subtilis IAM 12118 used as an outgroup and tree rooted at the outgroup. Each isolate was
allocated genus prefix based on top BLAST result of the 16S rRNA gene database. Taxa with species
level names were chosen from NCBI blast database for reference.
2.4. OSMAC Screen of 90 Isolates
Only a small fraction of the isolates showed antibacterial activity under their initial isolation
conditions (Figure 3). Therefore, we decided to utilise the “One Strain MAny Compounds” (OSMAC)
strategy [25] (Figure 6), which varies the cultivation conditions in an effort to force the activation of
‘silent’ gene clusters and, thus, cause the production of bioactive secondary metabolites. This method
was used to investigate the activity of 90 isolates from the collection, none of which originally
showed antibacterial activity. This selection included 57 unique strains (based on their 16S rRNA
gene sequences) and 33 strains that were isolated on the actinomycete-targeting media R2A and M1
(16S rRNA genes were not sequenced). Two OSMAC screens were designed using the 2018 review by
Romano et al. [26] as a guide. The first screen altered the composition of ISP2, a complex medium for
the isolation of fastidious actinomycetes [27], which had produced the most ‘hits’ during our initial
work (Table 2). The second screen used the more chemically defined M9 agar and altered the type and
concentration of carbon source present.
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sponge bacteria.
2.4.1. OSMAC Screen Using IPS2 Media
Strains were grown as small patches on ag lates of each OSMAC medium. The plates were
overlaid with a Gram-positive (S. aureus Ne an) and a Gram-negative (A. baumannii) pathogen,
and visible zones of inhibition indicated that the marine isolates were producing diffusible antibacterial
natural products. These clearance zones appeared markedly different on each of the OSMAC plates,
suggesting that these different conditions were indeed activating silent biosynthetic gene clusters
(Figure 7).
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Our rationale for each OSMAC condition for the ISP2 screen is as follows: Firstly, sponge-associated
bacteria may only produce antibiotics when stressed, so the OSMAC media accounts for this by
encompassing pH changes, hypersalinity (10% w/v NaCl compared to 3.5% for seawater [28]), cold,
heat and anaerobic shock. Secondly, sponge bacteria might also require certain biochemical signals to
produce antibiotics, so the media included sponge extract, NaBr, LaCl3, chitin, or γ-butyrolactone [26].
Finally, co-culturing marine bacteria with human pathogens has been shown to upregulate antibiotic
production, so we also used a suspension of lysed pathogens in one of the media conditions [29].
The first OSMAC screen used ISP2 as a base and the results shown in Figure 8 indicate that the
ability of bacteria to grow on an altered OSMAC agar was not linked to their ability to inhibit pathogen
growth. For example, over three times as many isolates grew on ISP2 at pH = 9 compared to pH = 5
(57 versus 16). However, fewer of the pH = 9 isolates inhibited pathogen growth; only 2 isolates versus
10 grown at pH = 5. Intriguingly almost all strains with antimicrobial activity showed activity on only
a single medium, implying a specific requirement for that condition rather than a general effect.
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We attempted to corroborate the results of the OSMAC screen by re-culturing and re-screening those
strains with antimicrobial activity. The growth inhibition w s recapitu ated in 61% of the re-cultured
strains (Figure 8c). The 16S rRNA genes of the strains with a timicrobial activity were sequenced
(Figure 8d). A significant proportion were human commensals (E. fergusonii, C. acnes, S. aureus),
which were assumed to be contaminants rather than sponge symbionts. However, the remainder
of the isolates were entirely consistent with the deep-sea origins of the samples [30,31], including
multiple samples of Kocuria rhizophila, Bacillus pumilus, Erythrobacter citreus, and Micrococcus yunnanensis
(Figure 8d, Supplementary Table S4). A comprehensive analysis of these bacteria is ongoing.
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2.4.2. OSMAC Screen Using M9 Media
The strains used in the ISP2 screen (Section 2.4.1) were screened in parallel with the well-defined
M9 media. This allowed variation of the carbon source; different carbon sources can inhibit or stimulate
the metabolic pathways that might lead to bioactive secondary metabolites [7,9].
A greater number of bacteria were recovered from OSMAC screens on M9 agar versus ISP2,
and this was largely insensitive to the carbon source (Figure 9a). M9 agar with 10 g/L dextrose
produced the greatest number of hits (Figure 9a), suggesting that carbon catabolite repression was not
significantly inhibiting natural product biosynthesis in these isolates. Again, most ‘hits’ only showed
activity on one medium (Figure 9b). Fifty-eight percent of the M9 hits showed activity again when
grown axenically (as a single species culture) and of these, three isolates were identified as human
commensals (Figure 9c). A significant proportion of the hits were again related to K. rhizophila and
E. citreus, similarly to the ISP2 media screen, but a Micromonospora and a Stappia species were unique to
the M9 screen. Only four of 22 growth-inhibiting strains were active in both screens, demonstrating
that using a wide range of conditions for an OSMAC screen is crucial.
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3. Discussion
Here we report a biodiscovery pipeline for the isolation and study of bacteria associated with
sponges harvested from previously inaccessible and unsurveyed areas, deep in the mid-Atlantic Ocean,
and the establishment of the Bristol Sponge Microbiome Collection (BISECT) of sponge-associated
marine microorganisms. This pipeline attempts to establish the potential of the contents of BISECT to
produce novel antimicrobial natural products, by using a suite of tools to isolate strains most likely to
have biosynthetic potential, such as those from the Actinomycetales order, and screen these strains
under multiple conditions to increase the probability of bioactivity.
Despite numerous advances in the field of bioprospecting, traditional screening approaches
continue to represent the dominant methodology that results in the discovery of novel compounds [32].
Successfully isolating novel producers is an essential part of reducing the risk of rediscovery and
maximising the usefulness of samples from underexplored environments. A previous study by
Esteves et al. [33] indicated that increasing media diversity represents an important strategy for
increasing the diversity of cultured bacteria. Even the most effective sponge culturing studies
(i.e., the most bacteria cultured in total) can only achieve ~10–14% recovery of species associated
with a sponge sample [34], and given the extreme nature of the deep-sea environment we expected
to achieve significantly less than this. While uncultured bacteria represent a promising avenue
for novel opportunities, such as uncultured sponge symbiont Entotheonella spp. [35], culture-based
approaches tend to select for bacteria with larger genomes, and larger genomes contain higher numbers
of biosynthetic gene clusters [36]. For these reasons, there is a compelling rationale for focusing future
efforts on optimising and diversifying the culture conditions employed during screening of the BISECT
collection. However, it is clear that the method we chose for screening the isolates for bioactivity
against pathogens (soft agar overlay assay) performed consistently, and allowed high throughput
testing of hundreds of isolates. Once our assay protocols were refined and diversified we could show
antibiotic activity for 13% of the strains cultured from sponge B01171.
A previous study of sea-sponge-associated bacteria isolated strains from five phyla: Cyanobacteria,
Actinobacteria, Bacteriodetes, Firmicutes and Proteobacteria [33]. This tallies with our findings,
and given that all the sponge samples processed in this study were collected at a depth of >200 m
the lack of photosynthetic Cyanobacteria is unsurprising. The increased numbers of Actinobacteria
and reduction in Bacteroidetes between sponges B0789 and B0078 suggests that our use of different
isolation media successfully encouraged the growth of bacterial species that are more likely to be
producing bioactive compounds. No Streptomyces species were recovered which is intriguing given
that this genus is usually well represented in culturing studies [37].
The actinomycetes genera recovered here have all been shown to demonstrate antimicrobial
activity when previously isolated from sponge tissue in the literature [38]. The one exception to this is
the Chryseoglobus genus, which at the time of writing has only one published species Chryseoglobus
frididaquae [39]. Whilst no activity was identified during the screen, full genome analysis will enable
further analysis of this rare deep-sea bacteria. Micrococcus and Kocuria dominated the overall diversity
of the isolated actinomycetes, and these talented genera are already responsible for the most potent
anti-MRSA compound identified from sponge associated bacteria. Kocurin is a thiazolyl peptide
antibiotic which was found to be produced by Micrococcus and Kocuria inhabited sponges in the Florida
Keys [31]. Notably, bioactive metabolites once thought to originate within the sponge have now been
reclassifed as metabolites of symbiotic Micrococcus [40]. Overall rare marine actinomycetes, such as
those isolated here, present an outstanding opportunity for future drug discovery [41].
Prior to OSMAC screens, we had identified only two unique species with antibacterial activity
from 487 isolates: a Micromonospora species and several isolates belonging to the Bacillus pumilus clade
that could not be distinguished by 16S rRNA gene sequencing [42]. Ninety bacterial strains that did not
show activity under their original isolation conditions were selected from the BISECT collection for use
in OSMAC screens. These included 57 unique strains (based on their 16S rRNA gene sequences) and
33 strains that were isolated on the actinomycete-targeting media R2A and M1 (16S rRNA genes were
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not sequenced). OSMAC screens of these 90 bacteria identified 22 unique strains with reproducible
antibacterial activity—a hit rate for this sub-sample of 24%.
Bacteria related to some of the active strains identified in this study have been reported to
have antibacterial activity. Micromonospora species are second only to Streptomyces as antibiotic
producers [43,44]. Bacillus species have started to be recognised as rich sources of bioactive
molecules [45]. As mentioned above, the novel peptide antibiotic kocurin was isolated from Kocuria
rhizophila and Micrococcus yunnanensis [31]. A marine isolate related to Erythrobacter citreus was found to
produce the cytotoxic natural product erythrazole B [46]. To the best of our knowledge, bioactive natural
products are yet to be reported from the genera Modestobacter and Stappia, which could make our
active isolates particularly promising as producers of novel compounds. We are now in the process of
extracting and characterising putative bioactive compounds from these strains.
The data presented herein hints at the abundance of novel microbially-derived chemistry present
within BISECT. This study provides a description of the development of this resource and allied
methodologies employed to date in the isolation and antimicrobial screening of bacterial strains
from deep-sea sponges and serves to confirm how valuable culture-dependent approaches are when
identifying marine-derived natural products. We hope that these data serve to nucleate interest and
engagement from academic colleagues in the BISECT collection, and we commit to making its contents
freely available to the academic community. Individuals interested in acquiring samples from BISECT
are encouraged to contact the corresponding authors of this manuscript in the first instance.
4. Materials and Methods
4.1. Sponge Sample Collection
The sponge samples were collected as part of the Tracing Ocean Processes Using Corals and
Sediments (TROPICS) research cruise in the equatorial Atlantic; from Tenerife to Trinidad aboard the
RRS James Cook (expedition JC094), using the ROV Isis (13/10/13–30/11/13). There were five sampling
locations from east to west: Carter and Knipovich seamounts in the eastern basin, the Vema fracture
zone at the Mid-Atlantic Ridge and the Vayda and Gramberg seamounts in the western basin.
The environmental conditions of the sites were recorded and varied as follows: temperature
(2.8–9.9 ◦C), salinity (34.9–35.1 PSU), and oxygen molality (36.8–236.3 umol/kg). There are four classes
of marine sponges—Calcarea, Demospongiae, Hexactinellida, and Homoscleromorpha—and all but the
last class were collected. The sponges were photographed and subsampled in a controlled-temperature
(4 ◦C) laboratory on board the ship before flash freezing them for storage at −80 ◦C.
4.2. Sponge Processing and Isolation of Bacterial Strains
Sponge samples (1 g) were washed three times in 50 mL sterile artificial sea water (ASW;
Crystal Sea Marine Mix, Marine Enterprise International, made to manufacturer’s instructions) for 30 s,
with rocking. The samples were suspended in sterile artificial sea water (50 mL) and homogenised
using a sterile pestle and mortar in a laminar flow hood to minimise environmental contamination.
The sponge homogenate was then serially diluted (10−1–10−4) with sterile artificial sea water and
spread onto a variety of agar types (Table S1). Duplicate plates were incubated at 28 ◦C and 4 ◦C for
between two weeks and two months. Colonies were picked based on morphology and streaked onto
fresh agar of the same type to grow as a monoculture in the same isolation temperature. The length of
time each species took to grow varied. The strains were then directly stocked from the agar plate into
Microorganism Preservation System Protect Cryotubes (Technical Service Consultants Ltd., Heylood,
UK) and stored at −70 ◦C.
All media was made with ASW to encourage the growth of obligate marine bacteria and
supplemented with cycloheximide (20 mg/mL) to inhibit the growth of fungi. For media targeting
actinomycetes sodium pyruvate (1 mM) was also added to encourage their growth, and nalidixic acid
(30 mg/mL) to inhibit the growth of Gram-negative bacteria.
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4.3. Sponge Extract Preparation
A sponge extract used to supplement the growth media was prepared as follows. Sponge tissue
(10 g) was homogenised in 30 mL phosphate buffered saline (PBS) over ice, then centrifuged (4700 rpm)
for 10 min to remove large debris, the supernatant was aspirated and diluted to 45 mL with PBS.
This was combined with 45 mL of methanol and then centrifuged (8500× g) for 10 min. The resulting
supernatant was filtered through a 0.2 µM filter and stored at 4 ◦C.
4.4. Soft Agar Overlay Antimicrobial Activity Assay
Strains were grown as small patches until there was visual growth. Staphylococcus aureus Newman,
S. aureus Mu50, Pseudomonas aeruginosa PA01, Escherichia coli BW55113, Klebsiella pneumoniae NCTC 5055
and Acinetobacter baumannii ATCC 19606 were grown in Mueller Hinton broth (Sigma-Aldrich), at 37 ◦C,
for 16 h. Each culture was suspended at OD600 = 0.01 in warm (42 ◦C), soft Mueller Hinton agar
(0.75% agar) and poured over the sponge bacterial isolates (10 mL/plate). The plates were incubated
at 37 ◦C, for 16 h. A visible zone of inhibition surrounding the strain indicated the test strain had
inhibited the growth of the pathogen.
4.5. 16S rRNA PCR Gene Amplification
Isolated colonies with distinct visual morphologies were re-streaked on their respective isolation
media to ensure a monoculture. Species identification was performed using 16S rRNA gene
amplification with universal bacterial primers 8F (5′ AGA GTT TGA TCC TGG CTC AG 3′) and 1512R
(5′ ACG GCT ACC TTG TTA CGA CTT 3′) [47] and enabled amplification of near full length 16S
rRNA gene fragment. Polymerase chain reaction (PCR) was conducted on bacterial genomic DNA
using Platinum™ Hot Start PCR Master Mix (2X) (ThermoFisher) or REDTaq® ReadyMix™ PCR
Reaction Mix (Sigma-Aldrich, St. Louis, MO, USA). The following cycle was used: heating to 94 ◦C for
10 min, then 35 cycles of denaturation (94 ◦C, 1 min), annealing (56 ◦C, 1 min) and extension (72 ◦C,
1.5 min), then a final elongation (72 ◦C, 10 min). The 16S rRNA gene product size (~1450 bp) was
confirmed using gel electrophoresis, then excised using the QIAquick Gel Extraction Kit (Qiagen) or
directly purified using the QIAquick PCR Purification Kit (Qiagen) according to the manufacturer’s
instructions. Amplicons were then Sanger sequenced (Eurofins Genomics) and the species identified
using BLAST and the 16S ribosomal database.
4.6. Phylogenetic Analysis
Combined 16S rRNA sequences for Actinobacteria were used to construct a neighbour-joining
tree. The phylogenetic tree was constructed with the Tamura–Nei model with a discrete gamma
distribution using MEGAX (10.1.8) (Mega Limited, Auckland, New Zealand) [48]. The constructed
tree was evaluated through bootstrap analysis performed 1000 times.
4.7. OSMAC Screening
Ninety bacterial isolates were assigned to a number and position on duplicate 45-membered grids
on a 120 mm Petri dish. Each isolate was spotted from its frozen glycerol stock onto an agar plate at
its assigned position in the grid. The plates were left to dry and incubated at 28 ◦C for seven days.
Plates were overlaid with S. aureus Newman or A. baumannii suspended in soft agar (as per Section 4.4).
The plates were then examined for clear zones where the growth of the pathogen was inhibited. When
more than one sponge isolate fell within a zone of inhibition they were all considered to be ‘hits’.
To verify the activities of these ‘hits’, each one was grown axenically on the same OSMAC medium at
28 ◦C for seven days and tested for activity using the soft agar overlay assay as above. This assay was
repeated in triplicate, and the ‘hits’ were classified as ‘hit again’, ‘no activity’ or ‘no growth’. For the
‘hit again’ isolates genomic DNA was extracted and the 16S rRNA genes were amplified using PCR
and then sequenced to classify the isolates (see Section 4.5).
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Two OSMAC screens were designed. The first screen used ISP2 (Supplementary Table S1) as a
complex base medium with variation in physical, chemical, and biological factors (Supplementary
Table S5). Colloidal chitin was prepared following the protocol used by Giubergia et al. 2016 [49],
and an aqueous sponge extract was prepared following the protocol used by Selvin et al. [50]. A ‘lysed
pathogens solution’ was prepared by collecting 5 µL each of freshly streaked colonies of E. coli BW25113,
S. aureus Newman, S. aureus Mu50, K. pneumoniae NCTC 5055, A. baumannii ATCC 19606, P. aeruginosa
PAO1, E. faecalis UB591, and B. subtilis and combining them together in 1 mL of PBS, and heating the
solution at 95 ◦C for 30 min. The sterility of the solution was verified by plating it on Mueller–Hinton
agar and checking for bacterial growth after incubation at 37 ◦C for 16 h. The second OSMAC screen
used M9 as a minimal base medium (Supplementary Table S6) and additional carbon sources (colloidal
chitin, dextrose, glycerol, mannitol, soluble starch and succinate) were added. M9 without the addition
of a carbon source was also used.
5. Conclusions
Here we report our first steps in characterising a new collection of deep-sea bacteria (BISECT)
and in understanding the biosynthetic potential of these isolates. Our initial focus is on antibiotic
discovery, prompted by the emerging global health crisis of antimicrobial resistance. In agreement
with previous studies, we show that a variety of deep-sea bacteria can be cultured under laboratory
conditions, and that these isolates should be grown on diverse media to promote the broadest range
of natural products. While further work is required to fully exploit this collection, our results are an
encouraging platform for further discovery.
Supplementary Materials: The following are available online at http://www.mdpi.com/2079-6382/9/8/509/s1,
Table S1. Agar composition; Table S2. Pathogenic bacterial strains used in this study; Table S3. Activity of ‘hit’
strains from B01171 using a soft agar overlay assay; Table S4. Closest relatives and activities of the 22 OSMAC
hits from the first screen on ISP2 media; Table S5. ISP2 media for first OSMAC screen; Table S6. M9 media for
second OSMAC screen, and supplementary references.
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